Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products; Draft Guidance for Industry; Availability

10 organizations filed 10 public comments on Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 237d ago.

Abstract

Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products; Draft Guidance for Industry; Availability

Commenters (10)

• American Academy of Pediatrics (AAP)

  1 filing · confidence 97%
• American Association for Cancer Researchtrade assoc.

  1 filing · confidence 85%
• CPAC Foundation Center for Regulatory Freedomtrade assoc.

  1 filing · confidence 85%
• Critical Path Institutetrade assoc.

  1 filing · confidence 85%
• Duke-Robert J. Margolis Institute for Health Policytrade assoc.

  1 filing · confidence 85%
• European Federation of Statisticians in the Pharmaceutical Industrytrade assoc.

  1 filing · confidence 85%
• Insmed Incorporatedunverified attribution

  1 filing · confidence 70%
• International Society of Pharmacoepidemiologytrade assoc.

  1 filing · confidence 85%
• Pediatric Inclusion Alliancetrade assoc.

  1 filing · confidence 85%
• Presentient Technologiesunverified attribution

  1 filing · confidence 70%